These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations. Ruane T; Haskins M; Cheng A; Wang P; Aguirre G; Knox VW; Qi Y; Tompkins T; O'Neill CA Mol Genet Metab; 2016 Feb; 117(2):157-63. PubMed ID: 26776148 [TBL] [Abstract][Full Text] [Related]
23. Sanfilippo A syndrome in the fetus. Greenwood RS; Hillman RE; Alcala H; Sly WS Clin Genet; 1978 Mar; 13(3):241-50. PubMed ID: 147760 [TBL] [Abstract][Full Text] [Related]
24. Genistein in Sanfilippo disease: a randomized controlled crossover trial. de Ruijter J; Valstar MJ; Narajczyk M; Wegrzyn G; Kulik W; Ijlst L; Wagemans T; van der Wal WM; Wijburg FA Ann Neurol; 2012 Jan; 71(1):110-20. PubMed ID: 22275257 [TBL] [Abstract][Full Text] [Related]
25. Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice. Beard H; Luck AJ; Hassiotis S; King B; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM Mol Genet Metab; 2015 May; 115(1):33-40. PubMed ID: 25795516 [TBL] [Abstract][Full Text] [Related]
26. A mouse model for mucopolysaccharidosis type III A (Sanfilippo syndrome). Bhaumik M; Muller VJ; Rozaklis T; Johnson L; Dobrenis K; Bhattacharyya R; Wurzelmann S; Finamore P; Hopwood JJ; Walkley SU; Stanley P Glycobiology; 1999 Dec; 9(12):1389-96. PubMed ID: 10561464 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of biomarkers for Sanfilippo syndrome. Saville JT; Flanigan KM; Truxal KV; McBride KL; Fuller M Mol Genet Metab; 2019; 128(1-2):68-74. PubMed ID: 31104888 [TBL] [Abstract][Full Text] [Related]
28. Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA. King B; Savas P; Fuller M; Hopwood J; Hemsley K Mol Genet Metab; 2006 Feb; 87(2):107-12. PubMed ID: 16352454 [TBL] [Abstract][Full Text] [Related]
29. Genomic basis of mucopolysaccharidosis type IIID (MIM 252940) revealed by sequencing of GNS encoding N-acetylglucosamine-6-sulfatase. Mok A; Cao H; Hegele RA Genomics; 2003 Jan; 81(1):1-5. PubMed ID: 12573255 [TBL] [Abstract][Full Text] [Related]
30. Caprine mucopolysaccharidosis IIID: fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations. Jones MZ; Alroy J; Downs-Kelly E; Lucas RE; Kraemer SA; Cavanagh KT; King B; Hopwood JJ J Mol Neurosci; 2004; 24(2):277-91. PubMed ID: 15456941 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS. Tanaka N; Kida S; Kinoshita M; Morimoto H; Shibasaki T; Tachibana K; Yamamoto R Mol Genet Metab; 2018 Sep; 125(1-2):53-58. PubMed ID: 30064964 [TBL] [Abstract][Full Text] [Related]
33. The laboratory diagnosis of Sanfilippo disease. Whiteman P; Young E Clin Chim Acta; 1977 Apr; 76(1):139-47. PubMed ID: 404099 [TBL] [Abstract][Full Text] [Related]
34. Low-dose, continuous enzyme replacement therapy ameliorates brain pathology in the neurodegenerative lysosomal disorder mucopolysaccharidosis type IIIA. King B; Hassiotis S; Rozaklis T; Beard H; Trim PJ; Snel MF; Hopwood JJ; Hemsley KM J Neurochem; 2016 May; 137(3):409-22. PubMed ID: 26762778 [TBL] [Abstract][Full Text] [Related]
35. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients. Kresse H; Von Figura K; Klein U Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835 [TBL] [Abstract][Full Text] [Related]
36. A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA. Shapiro EG; Nestrasil I; Delaney KA; Rudser K; Kovac V; Nair N; Richard CW; Haslett P; Whitley CB J Pediatr; 2016 Mar; 170():278-87.e1-4. PubMed ID: 26787381 [TBL] [Abstract][Full Text] [Related]
37. [Postnatal and prenatal diagnosis of mucopolysaccharidosis type III (Sanfilippo syndrome)]. Zhang WM; Shi HP; Meng Y; Li BT; Qiu ZQ; Liu JT Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):407-10. PubMed ID: 19099774 [TBL] [Abstract][Full Text] [Related]
38. Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA. King B; Marshall NR; Hassiotis S; Trim PJ; Tucker J; Hattersley K; Snel MF; Jolly RD; Hopwood JJ; Hemsley KM J Inherit Metab Dis; 2017 May; 40(3):443-453. PubMed ID: 27832416 [TBL] [Abstract][Full Text] [Related]
39. Sanfilippo syndrome, type D: a spectrophotometric assay with prenatal diagnostic potential. Nowakowski RW; Thompson JN; Taylor KB Pediatr Res; 1989 Nov; 26(5):462-6. PubMed ID: 2510119 [TBL] [Abstract][Full Text] [Related]